Complete financial analysis of Autek China Inc. (300595.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Autek China Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- IRB-Brasil Resseguros S.A. (IRBR3.SA) Income Statement Analysis – Financial Results
- EBR Systems, Inc. (EBR.AX) Income Statement Analysis – Financial Results
- L&F Co., Ltd. (066970.KQ) Income Statement Analysis – Financial Results
- Macfos Limited (ROBU.BO) Income Statement Analysis – Financial Results
- NextGen Acquisition Corp. II (NGCAU) Income Statement Analysis – Financial Results
Autek China Inc. (300595.SZ)
About Autek China Inc.
Autek China Inc. engages in the research, development, production, and sale of eye vision and related supporting products. It offers optometry medical devices, such as orthokeratology lenses for vision correction and myopia control. The company was founded in 2001 and is based in Hefei, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.74B | 1.53B | 1.30B | 870.66M | 646.90M | 458.42M | 311.63M | 235.02M | 176.24M | 129.88M | 91.01M | 68.39M |
| Cost of Revenue | 438.08M | 352.51M | 301.93M | 186.82M | 139.67M | 100.93M | 74.13M | 60.92M | 40.60M | 29.69M | 18.56M | 16.44M |
| Gross Profit | 1.30B | 1.17B | 993.11M | 683.84M | 507.23M | 357.49M | 237.50M | 174.10M | 135.64M | 100.19M | 72.45M | 51.94M |
| Gross Profit Ratio | 74.78% | 76.89% | 76.69% | 78.54% | 78.41% | 77.98% | 76.21% | 74.08% | 76.96% | 77.14% | 79.61% | 75.95% |
| Research & Development | 40.30M | 33.63M | 27.34M | 19.03M | 16.08M | 12.84M | 10.40M | 7.85M | 6.12M | 5.50M | 3.47M | 2.54M |
| General & Administrative | 44.09M | 44.76M | 41.21M | 25.46M | 21.00M | 24.90M | 11.10M | 4.08M | 4.61M | 3.28M | 21.42M | 5.43M |
| Selling & Marketing | 363.74M | 295.45M | 243.87M | 160.34M | 130.69M | 74.96M | 41.40M | 28.97M | 23.09M | 18.62M | 14.85M | 11.35M |
| SG&A | 406.93M | 340.21M | 285.08M | 185.80M | 151.69M | 99.86M | 52.51M | 33.05M | 27.70M | 21.89M | 36.27M | 16.79M |
| Other Expenses | -2.02M | 88.35M | 68.08M | 51.53M | 41.65M | 614.67K | -99.18K | 4.57M | 3.91M | 2.81M | 1.15M | 277.78K |
| Operating Expenses | 443.42M | 462.19M | 380.50M | 256.37M | 209.43M | 136.64M | 70.08M | 49.25M | 40.45M | 32.72M | 43.09M | 17.76M |
| Cost & Expenses | 881.50M | 814.70M | 682.43M | 443.19M | 349.10M | 237.57M | 144.21M | 110.17M | 81.05M | 62.42M | 61.65M | 34.21M |
| Interest Income | 13.50M | 17.54M | 4.89M | 1.73M | 1.99M | 1.91M | 1.67M | 112.62K | 85.85K | 108.33K | 62.88K | 0.00 |
| Interest Expense | 10.13M | 467.88K | 445.16K | 478.27K | 383.80K | 8.33K | 192.47K | 52.30K | 145.74K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 108.51M | 111.43M | 89.53M | 35.91M | 16.92M | 8.48M | 5.47M | 3.97M | 3.09M | 2.48M | 2.11M | -1.07M |
| EBITDA | 965.74M | 913.10M | 780.37M | 444.70M | 351.03M | 255.62M | 186.89M | 140.16M | 98.28M | 70.02M | 32.39M | 33.78M |
| EBITDA Ratio | 55.59% | 58.15% | 58.80% | 56.08% | 54.62% | 55.91% | 59.71% | 59.84% | 56.19% | 53.91% | 35.59% | 49.40% |
| Operating Income | 855.67M | 798.51M | 684.57M | 473.96M | 333.71M | 245.29M | 179.01M | 131.45M | 101.36M | 72.65M | 32.20M | 34.86M |
| Operating Income Ratio | 49.26% | 52.35% | 52.86% | 54.44% | 51.59% | 53.51% | 57.44% | 55.93% | 57.51% | 55.94% | 35.38% | 50.97% |
| Total Other Income/Expenses | -8.56M | -3.05M | -737.25K | -11.89M | 181.89K | 614.68K | -99.18K | 4.53M | 3.85M | 2.81M | 1.15M | 274.27K |
| Income Before Tax | 847.11M | 795.46M | 683.83M | 462.07M | 333.89M | 245.90M | 178.91M | 136.00M | 105.21M | 75.46M | 33.35M | 35.13M |
| Income Before Tax Ratio | 48.76% | 52.15% | 52.80% | 53.07% | 51.61% | 53.64% | 57.41% | 57.87% | 59.70% | 58.10% | 36.65% | 51.37% |
| Income Tax Expense | 118.13M | 98.78M | 92.23M | 18.10M | 39.02M | 36.13M | 30.32M | 22.11M | 16.86M | 12.52M | 8.55M | 5.05M |
| Net Income | 666.60M | 623.85M | 554.74M | 433.32M | 306.89M | 216.24M | 150.86M | 114.04M | 88.70M | 63.77M | 24.80M | 30.08M |
| Net Income Ratio | 38.37% | 40.90% | 42.84% | 49.77% | 47.44% | 47.17% | 48.41% | 48.52% | 50.33% | 49.10% | 27.25% | 43.99% |
| EPS | 0.75 | 0.72 | 0.65 | 0.51 | 0.36 | 0.26 | 0.18 | 0.18 | 0.14 | 0.10 | 0.04 | 0.05 |
| EPS Diluted | 0.75 | 0.72 | 0.65 | 0.51 | 0.36 | 0.26 | 0.18 | 0.18 | 0.14 | 0.10 | 0.04 | 0.05 |
| Weighted Avg Shares Out | 893.33M | 870.81M | 848.74M | 843.37M | 849.74M | 844.89M | 832.81M | 625.89M | 624.24M | 624.59M | 620.00M | 632.38M |
| Weighted Avg Shares Out (Dil) | 893.33M | 870.93M | 849.13M | 848.82M | 849.74M | 845.97M | 835.68M | 633.56M | 632.16M | 632.42M | 632.38M | 632.38M |
No news found for: 300595.SZ
Source: https://incomestatements.info
Category: Stock Reports